Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis

類似資料

• How can proton pump inhibitors damage central and peripheral nervous systems?
  著者:: Tigran Makunts, 等
  出版事項: (2020-01-01)
• How can proton pump inhibitors damage central and peripheral nervous systems?
  著者:: Makunts, Tigran, 等
  出版事項: (2020)
• Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
  著者:: Makunts, Tigran, 等
  出版事項: (2020)
• Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
  著者:: Cohen, Isaac V., 等
  出版事項: (2021)
• Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
  著者:: Makunts, Tigran, 等
  出版事項: (2019)